Related Experiment Video
Updated: Aug 20, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Guide to bone health and disease in cystic fibrosis
Robert M Aris1, Peter A Merkel, Laura K Bachrach
1CB 7020, 4131 Bioinformatics, University of North Carolina, Chapel Hill, North Carolina 27599-7524, USA. aris@med.unc.edu
Insights
Cystic fibrosis (CF) patients face significant bone disease risks, including low bone density and fractures. Addressing multiple risk factors is crucial for managing bone health in adults with CF.
Area of Science:
- Bone biology and genetics
- Pulmonary medicine
- Endocrinology
Background:
- Cystic fibrosis (CF) is a prevalent genetic disorder primarily affecting Caucasian populations, leading to respiratory failure.
- Increased lifespan in CF patients has revealed bone disease as a common complication, with 50-75% of adults experiencing low bone density and fractures.
- The rising number of adult CF survivors necessitates a focus on managing chronic complications like bone disease.
Framework:
- This review summarizes the Cystic Fibrosis Foundation's 2002 consensus conference on CF-related bone disease.
- It addresses the pathogenesis, diagnosis, and treatment of bone complications in cystic fibrosis.
- The goal was to establish practice guidelines for optimizing bone health in CF patients.
Implementation:
- Key risk factors for poor bone health in CF include pancreatic insufficiency affecting vitamin absorption, hormonal imbalances, chronic infections, physical inactivity, and corticosteroid use.
- Effective management requires a multifactorial approach targeting these specific risk factors.
- Early diagnosis and intervention are vital for preventing fractures and improving long-term outcomes.
Implications:
- Optimizing bone health is critical for the quality of life and long-term survival of individuals with cystic fibrosis.
- Developing and implementing evidence-based guidelines can significantly reduce the burden of bone disease in CF.
- Further research into the complex interplay of factors affecting bone metabolism in CF is warranted.
Abstract:
Cystic fibrosis (CF) is the most common genetic disease within the Caucasian population and leads to premature respiratory failure. Approximately 60,000 individuals are currently living with CF in North America and Europe, 40% of whom are adults. The life span of these patients has increased from approximately 2 to 32 yr of age over the last three decades. Bone disease has emerged as a common complication in long-term survivors of CF. Some studies have observed that 50-75% of adults have low bone density and increased rates of fractures. Prevention and treatment of CF-related bone disease must address the myriad risk factors (decreased absorption of fat-soluble vitamins due to pancreatic insufficiency, altered sex hormone production, chronic lung infection with increased levels of bone-active cytokines, physical inactivity, and glucocorticoid therapy) for poor bone health. This review is a condensed and updated summary of the Guide to Bone Health and Disease in Cystic Fibrosis: A Consensus Conference, a statement that evolved from a meeting convened by the Cystic Fibrosis Foundation in May 2002 to address the pathogenesis, diagnosis, and treatment of bone disease in CF. The goal of this conference was to develop practice guidelines for optimizing bone health in patients with CF.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
What is the Skeletal System?
Bone Remodeling and Repair

